LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹394 Cr | ₹346 Cr | ₹295 Cr | ₹262 Cr | ₹233 Cr |
What is the latest Net Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹346 Cr |
| Mar2023 | ₹295 Cr |
| Mar2022 | ₹262 Cr |
| Mar2021 | ₹233 Cr |
How is Net Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹394 Cr | 13.96 | |
| Mar2024 | ₹346 Cr | 17.09 | |
| Mar2023 | ₹295 Cr | 12.47 | |
| Mar2022 | ₹262 Cr | 12.65 | |
| Mar2021 | ₹233 Cr | - | |
Compare Net Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,208.8 Cr | 4.2% | -1.6% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 4.2% |
-1.6% |
14% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses